• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell . TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry

tetano

Editor, Senior Moderator
Cell


. 2023 Jul 3;S0092-8674(23)00645-1.
doi: 10.1016/j.cell.2023.06.005. Online ahead of print. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry

Jim Baggen[SUP] 1 [/SUP], Maarten Jacquemyn[SUP] 2 [/SUP], Leentje Persoons[SUP] 2 [/SUP], Els Vanstreels[SUP] 2 [/SUP], Valerie E Pye[SUP] 3 [/SUP], Antoni G Wrobel[SUP] 4 [/SUP], Valeria Calvaresi[SUP] 5 [/SUP], Stephen R Martin[SUP] 4 [/SUP], Chloë Roustan[SUP] 6 [/SUP], Nora B Cronin[SUP] 7 [/SUP], Eamonn Reading[SUP] 5 [/SUP], Hendrik Jan Thibaut[SUP] 8 [/SUP], Thomas Vercruysse[SUP] 8 [/SUP], Piet Maes[SUP] 9 [/SUP], Frederik De Smet[SUP] 10 [/SUP], Angie Yee[SUP] 11 [/SUP], Toey Nivitchanyong[SUP] 11 [/SUP], Marina Roell[SUP] 11 [/SUP], Natalia Franco-Hernandez[SUP] 11 [/SUP], Herve Rhinn[SUP] 11 [/SUP], Alusha Andre Mamchak[SUP] 11 [/SUP], Maxime Ah Young-Chapon[SUP] 11 [/SUP], Eric Brown[SUP] 11 [/SUP], Peter Cherepanov[SUP] 12 [/SUP], Dirk Daelemans[SUP] 13 [/SUP]



Affiliations
Free article Abstract

SARS-CoV-2 is associated with broad tissue tropism, a characteristic often determined by the availability of entry receptors on host cells. Here, we show that TMEM106B, a lysosomal transmembrane protein, can serve as an alternative receptor for SARS-CoV-2 entry into angiotensin-converting enzyme 2 (ACE2)-negative cells. Spike substitution E484D increased TMEM106B binding, thereby enhancing TMEM106B-mediated entry. TMEM106B-specific monoclonal antibodies blocked SARS-CoV-2 infection, demonstrating a role of TMEM106B in viral entry. Using X-ray crystallography, cryogenic electron microscopy (cryo-EM), and hydrogen-deuterium exchange mass spectrometry (HDX-MS), we show that the luminal domain (LD) of TMEM106B engages the receptor-binding motif of SARS-CoV-2 spike. Finally, we show that TMEM106B promotes spike-mediated syncytium formation, suggesting a role of TMEM106B in viral fusion. Together, our findings identify an ACE2-independent SARS-CoV-2 infection mechanism that involves cooperative interactions with the receptors heparan sulfate and TMEM106B.

Keywords: ACE2-independent entry; SARS-CoV-2; TMEM106B; TMEM106B crystal structure; antibody neutralization; coronavirus; cryo-EM; entry receptor.

 
Back
Top Bottom